Join Now

Category Archives: BioUtah News

Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

By admin | Published November 20, 2025

This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]

| Comments Off on Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

By Natalie Themm | Published November 13, 2025

100% of genes strongly recommended by national oncology guidelines are included in the MyRisk Test.

| Tagged | Comments Off on Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

New Preclinical Study Demonstrates Feasibility of Microbubble-Mediated, Non-Thermal Focused Ultrasound for Brain Tumor Ablation

By Natalie Themm | Published November 13, 2025

Salt Lake City, UT –Wednesday November, 5th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultrasound (FUS) using proprietary phase-shift microbubbles, NanoBlate (MVT-101), can selectively ablate brain tumors and open the blood-brain barrier (BBB) in targeted regions, potentially enabling safer, more precise, and […]

| Tagged | Comments Off on New Preclinical Study Demonstrates Feasibility of Microbubble-Mediated, Non-Thermal Focused Ultrasound for Brain Tumor Ablation

Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs

By Natalie Themm | Published November 13, 2025

Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared.

| Tagged | Comments Off on Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs

J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness

By Natalie Themm | Published November 13, 2025

Investigator-Initiated, grant-supported pilot study evaluating a novel non-prescription therapy for cancer-related vaginal dryness.

| Tagged | Comments Off on J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness

2025 BioUtah Life Sciences Awards Presented at the Mayer Brown Utah Life Sciences Summit

By Natalie Themm | Published November 13, 2025

BioUtah will honor outstanding leaders in Utah’s life sciences community with five awards recognizing contributions to the industry.

| Tagged | Comments Off on 2025 BioUtah Life Sciences Awards Presented at the Mayer Brown Utah Life Sciences Summit

PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

By Natalie Themm | Published November 6, 2025

PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

| Tagged | Comments Off on PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

By Natalie Themm | Published November 6, 2025

The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 months

| Tagged | Comments Off on Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

By Natalie Themm | Published November 6, 2025

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

| Tagged | Comments Off on Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

By Natalie Themm | Published November 6, 2025

Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives

| Tagged , | Comments Off on Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Health Insurance Costs 2026: Steep Increases Ahead for Employers, Including Life Sciences

By Natalie Themm | Published November 5, 2025

Health insurance costs are projected to rise sharply in 2026

Also posted in Guests Posts, HR | | Tagged | Comments Off on Health Insurance Costs 2026: Steep Increases Ahead for Employers, Including Life Sciences

Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics

By Natalie Themm | Published November 5, 2025

Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics

| Comments Off on Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics

A Special Thanks To Our Legacy and Platinum Elite Members